Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

This study is currently recruiting participants.
Verified July 2013 by Ethical Oncology Science
Sponsor:
Information provided by (Responsible Party):
Ethical Oncology Science
ClinicalTrials.gov Identifier:
NCT01283945
First received: January 25, 2011
Last updated: July 12, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)